JBIO
Jade Biosciences (JBIO)
NASDAQ
$21.35+$0.01 (+0.05%)
Price as of Aug 21, 2026 7:30 PM EDT
  • $1.4B
    Market Cap
  • 159.30%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-93.1M
+75.08%
-53.2M
-17.18%
-64.2M
+66.28%
-38.6M
+157.70%
Depreciation and Amortization Expense
26,000
-90.78%
282,000
+193.75%
96,000
+41.18%
68,000
+353.33%
Total Operating Expenses
113.5M
+52.21%
74.6M
-8.37%
81.4M
+52.92%
53.2M
+131.24%
Operating Profit
-113.5M
+52.21%
-74.6M
-8.37%
-81.4M
+52.92%
-53.2M
+131.24%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-13.8M
-374.94%
5.0M
-15.49%
5.9M
+239.46%
1.8M
+2,724.19%
Income before Taxes
-127.4M
+83.05%
-69.6M
-7.81%
-75.5M
+46.57%
-51.5M
+124.24%
Income Taxes
58,000
+5.45%
55,000
-1.79%
56,000
+124.00%
25,000
+733.33%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-127.4M
+82.99%
-69.6M
-7.80%
-75.5M
+46.61%
-51.5M
+124.32%
Net Income from Continuing Operations Applicable to Common
-127.4M
+83.05%
-69.6M
-7.81%
-75.5M
+46.57%
-51.5M
+124.24%
Basic EPS and Net Income
-3.19
+30.74%
-2.44
-14.98%
-2.87
+36.67%
-2.10
+12.30%
Diluted EPS and Net Income
-3.19
+30.74%
-2.44
-14.98%
-2.87
+36.67%
-2.10
+12.30%
Basic Weighted Average Shares
31.4M
+9.72%
28.6M
+8.55%
26.3M
+7.60%
24.5M
+99.06%
Diluted Weighted Average Shares
31.4M
+9.72%
28.6M
+8.55%
26.3M
+7.60%
24.5M
+99.06%
Balance Sheet
Cash and Cash Equivalents
88.4M
+162.03%
33.8M
+43.68%
23.5M
+4.88%
22.4M
-58.67%
Short-Term Investments
247.7M
+452.06%
44.9M
-54.65%
98.9M
-7.37%
106.8M
-5.62%
Cash and Cash Equivalents and Short-Term Investments
336.2M
+327.56%
78.6M
-35.79%
122.4M
-5.25%
129.2M
-22.80%
Total Current Assets
348.8M
+335.38%
80.1M
-35.51%
124.2M
-5.52%
131.5M
-24.57%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
170,000
+2,733.33%
6,000
-97.92%
288,000
+19.01%
242,000
+30.11%
Total Long-Term Assets
69,000
-96.98%
2.3M
0.00%
2.3M
-10.78%
2.6M
+747.68%
Total Assets
349.8M
+335.42%
80.3M
-36.95%
127.4M
-5.83%
135.3M
-22.85%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
16.5M
+332.05%
3.8M
-78.30%
17.6M
+126.64%
7.8M
+205.18%
Total Long-Term Debt
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
724,000
+183.92%
255,000
0.00%
255,000
-63.83%
705,000
+84.55%
Total Liabilities
17.3M
+342.87%
3.9M
-78.30%
18.0M
+109.89%
8.6M
+190.59%
Retained Earnings
-174.4M
-25.17%
-233.1M
+42.61%
-163.4M
+85.91%
-87.9M
+141.54%
Total Stockholders Equity
332.5M
+335.04%
76.4M
-30.17%
109.5M
-13.64%
126.7M
-26.49%
Total Shares Outstanding
49.3M
+70.14%
29.0M
+4.40%
27.8M
+12.30%
24.7M
+1.28%
Cash Flow
Cash from Operating Activities
-94.7M
+33.00%
-71.2M
+25.39%
-56.8M
+45.13%
-39.1M
+42.79%
Capital Expenditures
196,000
+38.03%
142,000
0.00%
142,000
-27.18%
195,000
+7.73%
Cash from Investing Activities
-247.0M
-540.85%
56.0M
+371.78%
11.9M
+71.47%
6.9M
+106.11%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
360.8M
+1,318.84%
25.4M
-44.72%
46.0M
+11,515.15%
396,000
-99.79%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-59.24%
-11.62%
-67.03%
+16.59%
-57.49%
+73.37%
-33.16%
N/A
Return on Equity
-62.31%
-16.82%
-74.91%
+17.15%
-63.95%
+85.69%
-34.44%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
21.09
+0.77%
20.93
+197.13%
7.04
-58.31%
16.90
N/A
Cash Ratio
5.35
-39.35%
8.82
+561.98%
1.33
-53.72%
2.88
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow